Pazopanib-d3 (hydrochloride)
Pazopanib-d3 (hydrochloride) (GW786034-d3 (hydrochloride) ) is deuterium labeled Pazopanib (Hydrochloride) . Pazopanib Hydrochloride (GW786034 Hydrochloride) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ, c-Kit, FGFR1, and c-Fms with an IC50 of 10, 30, 47, 84, 74, 140 and 146 nM, respectively.
Product Specifications
CAS Number
2469755-67-5
Product Name Alternative
GW786034-d3 (hydrochloride)
UNSPSC
12352005
Target
Autophagy; c-Fms; c-Kit; FGFR; Isotope-Labeled Compounds; PDGFR; VEGFR
Related Pathways
Autophagy; Others; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
O=S(C1=CC(NC2=NC=CC(N(C([2H])([2H])[2H])C3=CC4=NN(C)C(C)=C4C=C3)=N2)=CC=C1C)(N)=O.Cl
Molecular Formula
C21H21D3ClN7O2S
Molecular Weight
477.00
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Thakur A, et al. Pazopanib, a multitargeted tyrosine kinase inhibitor, reduces diabetic retinal vascular leukostasis and leakage. Microvasc Res. 2011 Nov;82 (3) :346-50.|[3]Harris PA, et al. Discovery of 5-[[4-[ (2,3-dimethyl-2H-indazol-6-yl) methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a novel and potent vascular endothelial growth factor receptor inhibitor. J Med Chem. 2008, 51 (15), 4632-4640.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC471573-500 1x 500 µL
N-Cadherin / Cadherin-2 / CD325 (NCAD) (CDH2/1573), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681604-500 1x 500 µL
CD4 (T-Helper/Inducer Cell Marker) (CD4/1604), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
